INTERNATIONAL SOCIETY OF BLOOD TRANSFUSION

34th International Congress of the ISBT

 

3-8 September 2016 Dubai
Close
N. Poster
Poster title
Applicant name
Status
  23-P COST-BENEFIT ANALYSIS AND VALIDATION OF THE RFID-BASED TRACEABILITY SYSTEM DEPLOYED IN SEVILLE-HUELVAS BLOOD ESTABLISHMENT Aida Agea Received Received
  28-P ECONOMIC MODELLING FOR TRANSFUSION MEDICINE IMPROVEMENT INITIATIVES IN NSW, AUSTRALIA Sally Francis Received Received
  37-P GLOBAL RISK MANAGEMENT SYSTEM : A PART OF MANAGEMENT AND DECISION MAKING WIDED SGHAIER Received Received
  59-P IMPROVEMENT OF QUALITY INDICATORS FOLLOWING IMPLEMENTATION OF REAL-TIME AUTOMATED RED BLOOD CELL ORDERING ALGORITHM BASED ON RETROSPECTIVE AND PROSPECTIVE HOSPITAL DATA JGQ Quinn Received Received
  138-P THE EFFECT OF A SINGLE WHOLE BLOOD DONATION ON COMPLETE BLOOD COUNT VALUES AND LYMPHOCYTE SUBSETS Mohammed Almohammadi Received Received
  143-P SIGNS AND SYMPTOMS OF VASOVAGAL DONOR ADVERSE REACTIONS Hany Kamel Received Received
  150-P VEIN SUITABILITY SCORING TO PREDICT PHLEBOTOMY OUTCOMES IN YOUNG WHOLE BLOOD DONORS Phillip Mondy Received Received
  160-P PROVIDING OF IMMUNOLOGICAL AND INFECTION PLATELET SAFETY BY CRYOPRESERVATION IV Vysochin Received Received
  190-P ARE THE CELL SEPARATORS SPECTRA OPTIA AND AMICUS EQUALLY SUITABLE FOR COLLECTION OF MNCS AND THEIR SUBSETS Gerda Leitner Received Received
  212-P IN VITRO EVALUATION OF WHOLE BLOOD-DERIVED THERAFLEX MB-PLASMA FOR REGISTRATION IN FRANCE Beatrice BELCOUR Received Received
  213-P EVALUATION OF WHOLE BLOOD-DERIVED PLASMA QUALITY TREATED WITH THE THERAFLEX PATHOGEN INACTIVATION SYSTEM FOR REGISTRATION IN FRANCE Stephane BEGUE Received Received
  214-P THROMBIN GENERATION TEST OF POOLED WHOLE BLOOD DERIVED PLASMA AFTER PHOTOCHEMICAL TREATMENT AND STORAGE Catherine RAVANAT Received Received
  240-P SEROPREVELANCE OF HEPATITIS E VIRUS (HEV) IN THE SWISS BLOOD DONORS: BASIS FOR FUTURE STRATEGY FOR PREVENTING HEV TRANSMISSION TO AT RISK INDIVIDUALS Christoph Niederhauser Received Received
  265-P SIXTEEN MONTH EXPERIENCE WITH THE COBAS MPX TEST ON THE COBAS 8800 SYSTEM IN A ROUTINE SCREENING SETTING Martin Stolz Received Received
  283-P PERFORMANCE OF A NEW AUTOMATED ASSAYS FOR HEPATITIS B SURFACE ANTIGEN AND HEPATITIS B CORE George Schlauder Received Received
  285-P PERFORMANCE OF A NEW AUTOMATED ASSAY FOR ANTIBODIES TO HEPATITIS C George Schlauder Received Received
  294-P PATTERNS IN HIV INCIDENCE IN REPEAT AND FIRST-TIME AND DONORS IN BRAZIL Brian Custer Received Received
  295-P PERFORMANCE OF A NEW AUTOMATED ASSAY FOR HIV George Schlauder Received Received
  303-P PERFORMANCE OF A NEW AUTOMATED ASSAY FOR SYPHILIS George Schlauder Received Received
  305-P PERFORMANCE OF A NEW AUTOMATED ASSAY FOR ANTIBODIES TO T. CRUZI George Schlauder Received Received
  315-P PERFORMANCE OF A NEW AUTOMATED ASSAY FOR HTLV I/II George Schlauder Received Received
  319-P COMPARISON OF THREE AUTOMATED BLOOD TYPING SYSTEMS FOR ABO/D TYPING IN ABO SUBGROUP Bo Kyeung Jung Received Received
  330-P DIRECT BLOOD GROUP TYPING USING MDMULTICARD LATERAL FLOW TECHNIQUE WITH ANTIBODIES FROM POLYCLONAL SOURCE Matteo Binda Received Received
  349-P COMPARISON OF SENSITIVITY AND SPECIFICITY OF THE BIO-RAD ID CARDS LISS/COOMBS WITH THE GRIFOLS GEL COOMBS CARDS IN A MANUAL APPROACH Hein Hustinx Received Received
  365-P NECESSITY OF TUBE METHOD IN RBC ANTIBODY SCREEN: PERSPECTIVE FROM A CASE OF COLD AGGLUTININ DISEASE Yanhua Li Received Received
  375-P PERFORMANCE CHARACTERISTICS OF A NOVEL ANTI-MIA MONOCLONAL ANTIBODY-BASED REAGENT IN A CANADIAN POPULATION John Saldanha Received Received
  377-P A PATIENT OF CAUCASIAN ORIGIN WITH ANTI-SC3 AND THE SC-NULL PHENOTYPE DUE TO A NOVEL ERMAP MUTATION Christine Henny Received Received
  403-P FREQUENCY OF ABO, RHESUS PHENOTYPES AND MOST PROBABLE GENOTYPES AND THE TYPE OF RHD NEGATIVE VARIANTS AMONG UAE NATIONALS IN AL AIN DISTRICT Mariam Al Meqbali Received Received
  458-P THERAPEUTIC PLASMA EXCHANGE: A TERTIARY CARE CENTER EXPERIENCE Maha Badawi Received Received
  459-P THERAPEUTIC PLASMA EXCHANGE WITH 5 ALBUMIN REPLACEMENT IN A PATIENT WITH CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME ON FONDAPARINUX Yanhua Li Received Received
  484-P MEASUREMENT FOR STRATEGIC IMPROVEMENT AND CLINICIAN FEEDBACK: PATIENT BLOOD MANAGEMENT IN NEW SOUTH WALES, AUSTRALIA Sally Francis Received Received
  492-P PLATELET TRANSFUSION EFFECTIVENESS Eugene Zhiburt Received Received
  499-P RETROSPECTIVE ANALYSIS OF TRANSFUSION REACTION REPORTING AT A TERTIARY HOSPITAL IN ABUDHABI Fatmah AlMazam Received Received
  501-P MECHANISMS UNDERPINNING TRANSFUSION RELATED IMMUNE MODULATION: ERYTHROPHAGOCYTOSIS AND IMMUNE MODULATION IN DIFFERENT MYELOID CELL SUBSETS Melinda Dean Received Received
  505-P HYPERHEMOLYSIS SYNDROME IN A SICKLE CELL DISEASE/THALASSEMIA PATIENT: THE ROLE OF IMMUNOTHERAPY Fatima Alkaabi Received Received
  532-P POTENTIAL USE OF THE ISBT 128 PRODUCT DESCRIPTION CODE DATABASE FOR HAEMOVIGILANCE REPORTING AND ANALYSIS Monica Freire Received Received
  533-P HOW TECHNOLOGY CONTRIBUTES TO REDUCE ERRORS IN TRANSFUSION PROCEDURES OF A TERTIARY-CARE HOSPITAL Nelly Carpio Martinez Received Received
  561-P RED BLOOD CELL TRANSFUSION IN TOTAL HIP AND KNEE REPLACEMENT Natalya Grechanyuk Received Received
  598-P DOES PATIENT HLA TYPE PREDICT THE RISK OF RED BLOOD CELL ALLOIMMUNIZATION? Ghada Mawad Received Received
Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
07:08
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

34th International Congress of the ISBT

 

3-8 September 2016 Dubai
FAQs
Virtual Poster Gallery
Search and consult posters online
in an exclusive section
for each poster
    ACTIVE FROM 03/09/2016 TO 03/09/2016
Poster
Gallery
Upload
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
                   DOI: 10.3252/pso.eu.34isbt.2016 




PosterSessionOnline
Logo Draft
 
Logo Cert